229 related articles for article (PubMed ID: 9802414)
1. Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Fisher TA; Ji H
Regul Pept; 1998 Sep; 75-76():231-8. PubMed ID: 9802414
[TBL] [Abstract][Full Text] [Related]
2. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system.
Pons J; Kitlinska J; Ji H; Lee EW; Zukowska Z
Can J Physiol Pharmacol; 2003 Feb; 81(2):177-85. PubMed ID: 12710532
[TBL] [Abstract][Full Text] [Related]
3. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity.
Nie M; Selbie LA
Regul Pept; 1998 Sep; 75-76():207-13. PubMed ID: 9802411
[TBL] [Abstract][Full Text] [Related]
5. HIV envelope protein gp120 induces neuropeptide Y receptor-mediated proliferation of vascular smooth muscle cells: relevance to AIDS cardiovascular pathogenesis.
Kim J; Ruff M; Karwatowska-Prokopczuk E; Hunt L; Ji H; Pert CB; Zukowska-Grojec Z
Regul Pept; 1998 Sep; 75-76():201-5. PubMed ID: 9802410
[TBL] [Abstract][Full Text] [Related]
6. Interactions of multiple signaling pathways in neuropeptide Y-mediated bimodal vascular smooth muscle cell growth.
Pons J; Kitlinska J; Jacques D; Perreault C; Nader M; Everhart L; Zhang Y; Zukowska Z
Can J Physiol Pharmacol; 2008 Jul; 86(7):438-48. PubMed ID: 18641693
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y Stimulates Proliferation and Migration of Vascular Smooth Muscle Cells from Pregnancy Hypertensive Rats via Y1 and Y5 Receptors.
Zhang P; Qi YX; Yao QP; Chen XH; Wang GL; Shen BR; Han Y; Gao LZ; Jiang ZL
PLoS One; 2015; 10(7):e0131124. PubMed ID: 26131716
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells.
Zukowska-Grojec Z; Pruszczyk P; Colton C; Yao J; Shen GH; Myers AK; Wahlestedt C
Peptides; 1993; 14(2):263-8. PubMed ID: 8483806
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y regulates rat renal tubular Na,K-ATPase through several signalling pathways.
Ohtomo Y; Ono S; Zettergren E; Sahlgren B
Acta Physiol Scand; 1996 Sep; 158(1):97-105. PubMed ID: 8876753
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
[TBL] [Abstract][Full Text] [Related]
12. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
King PJ; Widdowson PS; Doods HN; Williams G
J Neurochem; 1999 Aug; 73(2):641-6. PubMed ID: 10428060
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y stimulates DNA synthesis in human vascular smooth muscle cells through neuropeptide Y Y1 receptors.
Nilsson T; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):256-9. PubMed ID: 10721818
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system?
Zukowska Z; Pons J; Lee EW; Li L
Can J Physiol Pharmacol; 2003 Feb; 81(2):89-94. PubMed ID: 12710520
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Gonzalez-Montelongo MDC; Fountain SJ
Vascul Pharmacol; 2021 Feb; 136():106810. PubMed ID: 33181321
[TBL] [Abstract][Full Text] [Related]
19. Characterization of vascular postsynaptic NPY receptor function and regulation and differential sensitivity of Y1 and Y2 receptor function to changes in extracellular calcium availability and prior in vitro peptide exposure.
Tessel RE; Miller DW; Misse GA; Dong X; Doughty MB
Neuropeptides; 1993 Nov; 25(5):289-98. PubMed ID: 7509465
[TBL] [Abstract][Full Text] [Related]
20. Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists.
Evéquoz D; Grouzmann E; Beck-Sickinger AG; Brunner HR; Waeber B
Experientia; 1994 Oct; 50(10):936-8. PubMed ID: 7957768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
